Roivant Sciences Ltd. - Feb 18, 2025 Form SCHEDULE 13D/A Schedule Report for Arbutus Biopharma Corp (ABUS)

Filing Manager: Roivant Sciences Ltd.
Reporting Manager: Roivant Sciences Ltd.
Security: Arbutus Biopharma Corp Common Shares, without par value
Symbol: ABUS
Shares outstanding: 189M shares
Disclosed Ownership: 38.8M shares
Ownership: 20.5%
Form type: SCHEDULE 13D/A
Date filed: 2/18/2025, 05:21 PM
Date of event: Feb 18, 2025
Next filing: Feb 25, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Roivant Sciences Ltd.	20.5%	38.8M	38.8M	0	/s/ Keyur Parekh	Keyur Parekh, Authorized Signatory	0001635088